Does Rallies show Form 4 insider transactions for ASMB?

Yes. Rallies tracks ASMB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ASMB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ASMB. It does not provide personalized investment advice.

ASMB (Assembly Biosciences, Inc) Stock Analysis - Insider Trades

Assembly Biosciences, Inc (ASMB) is a publicly traded Healthcare sector company. As of May 21, 2026, ASMB trades at $26.34 with a market cap of $435.78M and a P/E ratio of -239.08. ASMB moved -0.92% today. Year to date, ASMB is -18.72%; over the trailing twelve months it is +81.48%. Its 52-week range spans $7.75 to $39.71. Analyst consensus is strong buy with an average price target of $44.33. Rallies surfaces ASMB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ASMB stock inside the company?

Recent ASMB insider activity includes Bjorkquist Jeanette M sold 312, Bjorkquist Jeanette M sold 16, White Nicole S sold 188, White Nicole S sold 9, and McHutchison John G sold 757. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ASMB Key Metrics

Key financial metrics for ASMB
Metric	Value
Price	$26.34
Market Cap	$435.78M
P/E Ratio	-239.08
EPS	$-0.11
Dividend Yield	0.00%
52-Week High	$39.71
52-Week Low	$7.75
Volume	337
Avg Volume	0
Revenue (TTM)	$71.10M
Net Income	$-6.38M
Gross Margin	0.00%

Recent ASMB Insider Trades

Bjorkquist Jeanette M sold 312 (~$8.31K) on Mar 30, 2026.
Bjorkquist Jeanette M sold 16 (~$439.84) on Mar 30, 2026.
White Nicole S sold 188 (~$5.01K) on Mar 30, 2026.
White Nicole S sold 9 (~$247.41) on Mar 30, 2026.
McHutchison John G sold 757 (~$7.46K) on Mar 31, 2025.

Latest ASMB News

Assembly Biosciences to Present Phase 1a Safety Data on Oral HDV Entry Inhibitor ABI-6250 — May 13, 2026
Assembly Biosciences Posts Q1 Net Loss of $9.1M, $226.6M Cash; Advances Clinical Candidates — May 7, 2026
Assembly Biosciences to Present ABI-5366 Dosing and ABI-1179 Late-Breaker Data at ESCMID 2026 — Apr 9, 2026
Assembly Biosciences Secures $35M for HPI Program, Cash Runway Into 2028 — Mar 19, 2026

ASMB Analyst Consensus

3 analysts cover ASMB: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $44.33.

Common questions about ASMB

Who is trading ASMB stock inside the company?: Recent ASMB insider activity includes Bjorkquist Jeanette M sold 312, Bjorkquist Jeanette M sold 16, White Nicole S sold 188, White Nicole S sold 9, and McHutchison John G sold 757. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ASMB?: Yes. Rallies tracks ASMB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ASMB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ASMB. It does not provide personalized investment advice.